Advertiser: Bayer (拜耳) - Apixaban (阿呱沙班),Bayer (拜耳) - Dabigatran (達比加群酯),Bayer (拜耳) - Rivaroxaban (利伐沙班)
Admendment: Category / Sub-Category / Advertiser / Brand / Brand Percentage of Bayer (拜耳) - Apixaban (阿呱沙班),Bayer (拜耳) - Dabigatran (達比加群酯),Bayer (拜耳) - Rivaroxaban (利伐沙班) have been amended
Result: Adspend of Category / Sub-Category / Advertiser / Brand / Brand Percentage would be affected
Affected Period: 09 October 2014 to 09 October 2014
Affected Media: PRINT
Action: 14news10096059
From
Miscellaneous > Miscellaneous
Miscellaneous > Miscellaneous Brands (100%)
To
Pharmaceuticals & Healthcare > Heart & Internal Circulation
Bayer (拜耳) - Apixaban (阿呱沙班) > Heart & Internal Circulation (33%)
Pharmaceuticals & Healthcare > Heart & Internal Circulation
Bayer (拜耳) - Dabigatran (達比加群酯) > Heart & Internal Circulation (33%)
Pharmaceuticals & Healthcare > Heart & Internal Circulation
Bayer (拜耳) - Rivaroxaban (利伐沙班) > Heart & Internal Circulation (34%)
